Roche CFO Erich Hunziker announced that the company will go to bond investors to help finance its proposed $42.1-billion takeover of Genentech, and the drugmaker also plans a commercial paper programme for as much as $10 billion. Hunziker also stated that it will limit the size of acquisitions for the next two to three years should its bid for Genentech be successful.
More
No comments:
Post a Comment